| Year |
Citation |
Score |
| 2011 |
Klöckener T, Hess S, Belgardt BF, Paeger L, Verhagen LA, Husch A, Sohn JW, Hampel B, Dhillon H, Zigman JM, Lowell BB, Williams KW, Elmquist JK, Horvath TL, Kloppenburg P, et al. High-fat feeding promotes obesity via insulin receptor/PI3K-dependent inhibition of SF-1 VMH neurons. Nature Neuroscience. 14: 911-8. PMID 21642975 DOI: 10.1038/Nn.2847 |
0.394 |
|
| 2010 |
Xu Y, Hill JW, Fukuda M, Gautron L, Sohn JW, Kim KW, Lee CE, Choi MJ, Lauzon DA, Dhillon H, Lowell BB, Zigman JM, Zhao JJ, Elmquist JK. PI3K signaling in the ventromedial hypothalamic nucleus is required for normal energy homeostasis. Cell Metabolism. 12: 88-95. PMID 20620998 DOI: 10.1016/J.Cmet.2010.05.002 |
0.347 |
|
| 2009 |
Hawke Z, Ivanov TR, Bechtold DA, Dhillon H, Lowell BB, Luckman SM. PACAP neurons in the hypothalamic ventromedial nucleus are targets of central leptin signaling. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 29: 14828-35. PMID 19940178 DOI: 10.1523/JNEUROSCI.1526-09.2009 |
0.372 |
|
| 2008 |
Zhang R, Dhillon H, Yin H, Yoshimura A, Lowell BB, Maratos-Flier E, Flier JS. Selective inactivation of Socs3 in SF1 neurons improves glucose homeostasis without affecting body weight. Endocrinology. 149: 5654-61. PMID 18669597 DOI: 10.1210/En.2008-0805 |
0.415 |
|
| 2006 |
Dhillon H, Zigman JM, Ye C, Lee CE, McGovern RA, Tang V, Kenny CD, Christiansen LM, White RD, Edelstein EA, Coppari R, Balthasar N, Cowley MA, Chua S, Elmquist JK, et al. Leptin directly activates SF1 neurons in the VMH, and this action by leptin is required for normal body-weight homeostasis. Neuron. 49: 191-203. PMID 16423694 DOI: 10.1016/J.Neuron.2005.12.021 |
0.376 |
|
| 2005 |
Kershaw EE, Morton NM, Dhillon H, Ramage L, Seckl JR, Flier JS. Adipocyte-specific glucocorticoid inactivation protects against diet-induced obesity. Diabetes. 54: 1023-31. PMID 15793240 |
0.392 |
|
| 2002 |
Beretta E, Dhillon H, Kalra PS, Kalra SP. Central LIF gene therapy suppresses food intake, body weight, serum leptin and insulin for extended periods. Peptides. 23: 975-84. PMID 12084530 DOI: 10.1016/S0196-9781(02)00021-9 |
0.656 |
|
| 2002 |
Dube MG, Beretta E, Dhillon H, Ueno N, Kalra PS, Kalra SP. Central leptin gene therapy blocks high-fat diet-induced weight gain, hyperleptinemia, and hyperinsulinemia: increase in serum ghrelin levels. Diabetes. 51: 1729-36. PMID 12031959 DOI: 10.2337/Diabetes.51.6.1729 |
0.63 |
|
| 2001 |
Dhillon H, Kalra SP, Kalra PS. Dose-dependent effects of central leptin gene therapy on genes that regulate body weight and appetite in the hypothalamus Molecular Therapy. 4: 139-145. PMID 11482985 DOI: 10.1006/Mthe.2001.0427 |
0.66 |
|
| 2001 |
Dhillon H, Kalra SP, Prima V, Zolotukhin S, Scarpace PJ, Moldawer LL, Muzyczka N, Kalra PS. Central leptin gene therapy suppresses body weight gain, adiposity and serum insulin without affecting food consumption in normal rats: a long-term study. Regulatory Peptides. 99: 69-77. PMID 11384767 DOI: 10.1016/S0167-0115(01)00237-3 |
0.68 |
|
| 2000 |
Dhillon H, Ge Y, Minter RM, Prima V, Moldawer LL, Muzyczka N, Zolotukhin S, Kalra PS, Kalra SP. Long-term differential modulation of genes encoding orexigenic and anorexigenic peptides by leptin delivered by rAAV vector in ob/ob mice. Relationship with body weight change. Regulatory Peptides. 92: 97-105. PMID 11024571 DOI: 10.1016/S0167-0115(00)00155-5 |
0.616 |
|
| 2000 |
Pu S, Dhillon H, Moldawer LL, Kalra PS, Kalra SP. Neuropeptide Y counteracts the anorectic and weight reducing effects of ciliary neurotropic factor Journal of Neuroendocrinology. 12: 827-832. PMID 10971807 DOI: 10.1046/J.1365-2826.2000.00526.X |
0.636 |
|
| Show low-probability matches. |